Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What Factors Are Driving the Anticipated Growth Rate of the ACE Inhibitors Market Through 2034?

The market for ACE inhibitors has seen a consistent increase in size over the past few years. The market, which is valued at $7.15 billion in 2024, is projected to rise to $7.48 billion in 2025, reflecting a compound annual growth rate (CAGR) of 4.6%. The expanding rate in the preceding years can be credited to several factors including, an elevated incidence of cardiovascular ailments, a growing elderly population, proven clinical efficacy and safety, rising incidence of diabetes, and supportive regulatory approvals and guidelines.

In the coming years, the ACE inhibitors market is projected to witness robust expansion, estimated to reach “$9.6 billion by 2029, with a compound annual growth rate (CAGR) of 6.4%. This surge during the forecast period is largely due to the escalating global prevalence of cardiovascular ailments, broadening hypertension treatment protocols, advancements in combined therapies, emphasis on managing heart failure, and an upswing in awareness and access to healthcare. Key trends anticipated during the forecast period comprise focus on nephroprotection, a shift towards renin-angiotensin system inhibitors, rising generic competition and price constraints, adopting patient-focussed healthcare practices, and tweaks in regulations and safety measures.

What Drivers Are Shaping the Growth of the ace inhibitors Market?

The ACE inhibitors market is expected to grow due to the rising prevalence of hypertension disorders. Hypertension, commonly recognized as high blood pressure, is defined by increased pressure within the blood vessels. Angiotensin-converting enzyme inhibitors, better known as ACE inhibitors, are a cluster of drugs aimed at managing and controlling hypertension. They work by easing the blood vessels, thereby reducing blood pressure and enhancing blood circulation. As per the World Health Organization, a United Nations’ specialized agency based in Switzerland, nearly 1.28 billion adults aged between 30-79 suffered from hypertension globally in March 2023. The majority of these individuals lived in low- to middle-income countries. Over the past three decades, the count of people between 30-79 years with hypertension rose by 650 million. Intriguingly, 46% of adults suffering from hypertension are estimated to be unaware of their condition due to lack of proper diagnosis. This escalating occurrence of hypertension disorders is fueling the expansion of the ACE inhibitors market.

Get Your Free Sample of the Global ACE Inhibitors Market Report Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=10671&type=smp

Who Are the Major Industry Leaders Accelerating Growth in the ACE Inhibitors Market?

Major companies operating in the ACE inhibitors market include:

• Pfizer Inc._x000D_

• Novartis AG_x000D_

• Johnson & Johnson Private Limited_x000D_

• Merck KGaA_x000D_

• Sanofi S.A._x000D_

Which Current Trends Are Having the Most Impact on the ACE Inhibitors Market?

One primary trend shaping the field of ACE inhibitors is the focus on product innovations. Key players in the market are concentrating on the development of novel products in order to solidify their market positioning and gain an edge over their competitors. An example of this was in February 2023, when Travere Therapeutics, a biopharmaceutical firm from the United States, received FDA approval for FILSPARI (sparsentan). This unique non-immunosuppressive therapy is purposed for the treatment of patients with IgA nephropathy (IgAN). The therapy encompasses systematic glucocorticoids, ACE inhibitors, as well as antihypertensive drugs, inclusive of angiotensin-receptor blockers (ARBs). The standout feature of this therapy is its non-immunosuppressive nature and it is the only of its kind to be approved. It is a daily orally-taken medication, developed to be used by adults with primary IgAN who are at a high risk of accelerated disease progress and usually have a UPCR under 1.5 g/g, alongside proteinuria.

Get Instant Access to the Global ACE Inhibitors Market Report with Swift Delivery!

https://www.thebusinessresearchcompany.com/report/ace-inhibitors-global-market-report

What Are the Major Categories and Their Growth Dynamics in the ACE Inhibitors Market?

The ACE inhibitors market covered in this report is segmented –

1) By Type: Sulfhydryl-containing Agents, Dicarboxylate-containing Agents, Phosphonate-containing Agents

2) By Drug: Ramipril, Enalapril, Benazepril, Fosinopril, Captopril, Moexipril, Other Drugs

3) By Dosage Form: Oral Tablets, Oral Solutions

4) By Application: Heart Failure, Chronic Kidney Disease, Hypertension, Diabetes, Heart Attack, Other Applications

5) By End-Users: Hospitals, Online Drug Stores, Other End-Users

Subsegments:

1) By Sulfhydryl-Containing Agents: Captopril, Zofenopril

2) By Dicarboxylate-Containing Agents: Enalapril, Lisinopril, Ramipril, Quinapril, Benazepril, Perindopril

3) By Phosphonate-Containing Agents: Fosinopril

Which Regions Are Key Players in the Growth of the ACE Inhibitors Market?

North America was the largest region in the ACE inhibitors market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global ACE inhibitors market report during the forecast period. The regions covered in the ace inhibitors market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Key Elements Shape the Definition of the ACE Inhibitors Market?

ACE inhibitors, also known as angiotensin-converting enzyme (ACE) inhibitors, refer to a type of medication used to treat and manage hypertension. They function by stopping the body’s enzyme from generating angiotensin II, a chemical that constricts blood vessels and raises blood pressure. Its basic function is to relax the veins and arteries to reduce blood pressure.

Browse Through More Similar Reports By The Business Research Company:

Surveillance Technology Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/surveillance-technology-global-market-report

Synthetic Biology Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/synthetic-biology-global-market-report

Alpha Mannosidosis Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/alphas-mannosidosis-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: